Custom immune cells take on advanced colorectal cancer in new trial
NCT ID NCT07504523
First seen Apr 12, 2026 · Last updated Jun 10, 2026 · Updated 11 times
Summary
This early-stage study is testing a new personalized treatment called iNeo-Vac-T01 for people with advanced colorectal cancer that hasn't responded to standard therapies. The treatment uses a patient's own immune cells, which are specially trained in the lab to recognize and attack unique markers on their cancer. The main goals are to see if this approach is safe, feasible, and shows any signs of shrinking tumors.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC COLORECTAL CANCER (CRC) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
2nd Affiliated Hospital, School of Medicine, Zhejiang University, China
RECRUITINGHangzhou, Zhejiang, 310009, China
Conditions
Explore the condition pages connected to this study.